Skip to content
Guavy Logo GUAVY
Sign up
Back to Guavy Wire
Stocks

HSBC Raises Price Target for Merck & Co. to $172.00

Guavy AI Editorial Team
Instruments
MRK
Share

HSBC has raised its price target for Merck & Co., Inc. (NYSE:MRK) from $150.00 to $172.00, according to a report issued on Thursday by Benzinga.

The firm currently has a 'buy' rating on the stock and the new price target suggests a potential upside of 17.47% from the company's previous close.

This is not the only analyst who has raised their target for Merck & Co., Inc. Scotiabank increased its target price on the company from $136.00 to $155.00 and gave the stock a 'sector outperform' rating in a research note on June 30th.

More on Stocks

Stocks just now

Google Cloud Unveils Industry-Specific Initiative with Gemini Enterprise

Stocks just now

Google Data Centers Get Green Light from Oklahoma Regulators

Stocks 1m ago

Android Enables Seamless Password Transfer Between Managers

Disclaimer: Guavy is a data and market intelligence provider, not an investment adviser. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.

Guavy Logo GUAVY

Market sentiment intelligence for apps, funds & agents

Location

729 55 Ave SW
Calgary AB T2V 0G4
Canada

Navigate

Markets

Resources

© 2026 Guavy Inc

Terms Privacy Policy